Trial Profile
A study to evaluate the incidence of rotavirus gastroenteritis hospitalizations before and after introduction of RotaTeq
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2018
Price :
$35
*
At a glance
- Drugs Rotavirus W179-9 vaccine (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- 12 Nov 2016 New trial record
- 19 Oct 2016 Results published in the Vaccine